Hunan HuaTeng Pharmaceutical Co Ltd

Huateng Pharma is a contract development and manufacturing organization (CDMO) that specializes in the development and production of pharmaceutical molecules, particularly PEG derivatives, API intermediates, and active pharmaceutical ingredients (APIs). The company offers a range of services, including custom synthesis, PEGylation, and contract manufacturing, to support the development and production of pharmaceutical products. Huateng Pharma has a strong focus on research and development, with a 5,000m² R&D center and a 34,000m² state-of-the-art manufacturing site capable of producing products from gram to ton scale. The company's product portfolio includes thousands of PEG derivatives, pharmaceutical intermediates, and APIs, which are used in a variety of applications, including long-acting targeted drug delivery, medical device renovation, and diagnostic analysis.

Hunan Huateng Pharmaceutical Co., Ltd. , founded in August 2013​, is a high-tech enterprise dedicated to the research and development and production of high-end biomedical chemical products, as well as the development of precision targeted anti-tumor drugs. The company develops and produces thousands of products, including monodisperse and polydisperse PEG derivatives, high-end biochemical reagents, pharmaceutical intermediates, APIs, preparations and targeted anti-tumor drugs.